Rokos Capital Management LLP Novavax Inc Transaction History

Rokos Capital Management LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $4.43 Million - $12.5 Million	500,000 New	500,000 $5.14 Million
Q1 2021 May 13, 2021	SELL	$112.98 - $319.93 $3.27 Million - $9.25 Million	-28,925 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $2.28 Million - $4.04 Million	28,925 New	28,925 $3.3 Million

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Rokos Capital Management LLP, based on Form 13F filings with the SEC.

Stay updated on Rokos Capital Management LLP with notifications on news.